OSAplex
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
OSAplex (XYMOGEN), a food supplement au code-barres 871149002367, is described by its US market label, recorded on 25 September 2025. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 25 September 2025. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 100 µg a day according to the label (at most 2 servings a day), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Calcium: up to 1,100 mg a day according to the label (at most 2 servings a day), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149002367
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hypromellose, Water, Stearic Acid, Magnesium Stearate, Medium Chain Triglyceride Oil, Silica, Microcrystalline Cellulose, Hypromellose, Water, Water, Purified
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Choline | Vitamin | not stated |
| Silicon | Mineral | not stated |
| Vitamin D3 | Vitamin | 50 µg |
| Calcium | Mineral | 550 mg |
| Phosphorus | Mineral | 198 mg |
| Microcrystalline Hydroxyapatite Concentrate | Mineral | 2.2 Gram(s) |
| Microcrystalline Hydroxyapatite | Mineral | 1.32 Gram(s) |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: OSAplex
Entered into DSLD on 21 December 2024. Retirée du marché américain le 9 April 2025 (selon le DSLD).Same active composition.
Official label: OSAplex
Entered into DSLD on 22 January 2021. Retirée du marché américain le 8 September 2023 (selon le DSLD).- Same quantity, different name: MCHC in this version; Microcrystalline Hydroxyapatite Concentrate on the displayed label (2.2 Gram(s))
Official label: OSAplex
Entered into DSLD on 25 January 2018. Retirée du marché américain le 6 July 2020 (selon le DSLD).- Same quantity, different name: MCHC in this version; Microcrystalline Hydroxyapatite Concentrate on the displayed label (2.2 Gram(s))
- Different unit, without conversion : Vitamin D3: 2,000 IU in this version; 50 mcg on the displayed label
Official label: OSAplex
Entered into DSLD on 25 August 2015. Retirée du marché américain le 29 September 2017 (selon le DSLD).- Same quantity, different name: MCHC in this version; Microcrystalline Hydroxyapatite Concentrate on the displayed label (2.2 Gram(s))
- Different unit, without conversion : Choline: 60 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Silicon: 3 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Vitamin D3: 2,000 IU in this version; 50 mcg on the displayed label
Official label: OSAplex
Entered into DSLD on 24 December 2013. Retirée du marché américain le 24 February 2015 (selon le DSLD).- Same quantity, different name: MCHC in this version; Microcrystalline Hydroxyapatite Concentrate on the displayed label (2.2 Gram(s))
- Different unit, without conversion : Vitamin D3: 2,000 IU in this version; 50 mcg on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : XYMOGEN